William Blair & Company’s Albireo Pharma Inc ALBO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-15,456
| Closed | -$334K | – | 1871 |
|
|
2022
Q4 | $334K | Buy |
15,456
+75
| +0.5% | +$1.58K | ﹤0.01% | 1182 |
|
|
2022
Q3 | $298K | Sell |
15,381
-22,455
| -59% | -$464K | ﹤0.01% | 1235 |
|
|
2022
Q2 | $751K | Sell |
37,836
-18,035
| -32% | -$476K | ﹤0.01% | 938 |
|
|
2022
Q1 | $1.67M | Sell |
55,871
-16,967
| -23% | -$497K | 0.01% | 748 |
|
|
2021
Q4 | $1.7M | Sell |
72,838
-10,775
| -13% | -$286K | 0.01% | 772 |
|
|
2021
Q3 | $2.61M | Buy |
83,613
+23,071
| +38% | +$714K | 0.01% | 631 |
|
|
2021
Q2 | $2.13M | Buy |
60,542
+1,117
| +2% | +$36.3K | 0.01% | 692 |
|
|
2021
Q1 | $2.1M | Buy |
59,425
+5,552
| +10% | +$205K | 0.01% | 676 |
|
|
2020
Q4 | $2.02M | Buy |
53,873
+6,059
| +13% | +$220K | 0.01% | 648 |
|
|
2020
Q3 | $1.6M | Buy |
47,814
+10,970
| +30% | +$320K | 0.01% | 640 |
|
|
2020
Q2 | $976K | Sell |
36,844
-3,582
| -9% | -$84.5K | ﹤0.01% | 727 |
|
|
2020
Q1 | $662K | Buy |
40,426
+1,338
| +3% | +$29.4K | ﹤0.01% | 791 |
|
|
2019
Q4 | $994K | Sell |
39,088
-7,827
| -17% | -$157K | 0.01% | 780 |
|
|
2019
Q3 | $938K | Sell |
46,915
-1,195
| -2% | -$30.9K | 0.01% | 766 |
|
|
2019
Q2 | $1.55M | Buy |
48,110
+18,911
| +65% | +$632K | 0.01% | 649 |
|
|
2019
Q1 | $940K | Buy |
29,199
+1,677
| +6% | +$45.1K | 0.01% | 749 |
|
|
2018
Q4 | $675K | Buy |
+27,522
| New | +$727K | ﹤0.01% | 814 |
|
|
2015
Q1 | – | Sell |
-12,369
| Closed | -$1.3M | – | 2208 |
|
|
2014
Q4 | $1.3M | Buy |
12,369
+2,198
| +22% | +$96.5K | ﹤0.01% | 1398 |
|
|
2014
Q3 | $860K | Sell |
10,171
-15,433
| -60% | -$887K | ﹤0.01% | 1522 |
|
|
2014
Q2 | $1.88M | Sell |
25,604
-15,420
| -38% | -$1.07M | ﹤0.01% | 1261 |
|
|
2014
Q1 | $3.46M | Hold |
41,024
| – | – | 0.01% | 1048 |
|
|
2013
Q4 | $4.21M | Hold |
41,024
| – | – | 0.01% | 968 |
|
|
2013
Q3 | $3.27M | Hold |
41,024
| – | – | 0.01% | 997 |
|
|
2013
Q2 | $3.21M | Buy |
+41,024
| New | +$4.27M | 0.01% | 965 |
|
